Nicholas Sarlis: Advancing Precision Oncology Through Emerging Scientific Talent
Nicholas Sarlis/researchgate.net

Nicholas Sarlis: Advancing Precision Oncology Through Emerging Scientific Talent

Nicholas Sarlis, Chief Medical Officer of CLEARA Biotech BV, shared on LinkedIn:

” ‘Investing in rising talent is how Precision Oncology Consulting (POC) accelerates innovation in oncology!’

When Sofía Navas Gnesdilova joined Precision Oncology Consulting as a Scientific Analyst Intern this past summer, her deep domain knowledge in genetics and precision oncology immediately set her apart. Dr. Svetlana Nikic, recently announced Sofía’s official transition to Junior Consultant.

As a senior global advisor, I can attest that in specialized consultancy, technical rigor alone isn’t enough – impact requires bridging bench science with commercial reality.

Sofía’s work exemplifies that balance:

  • Translating complex science: Driving strategic communication and targeted content planning for high-stakes healthcare initiatives.
  • Navigating commercial pathways: Strengthening market access capabilities to help novel personalized therapies reach target patient populations.
  • Executing with agility: Supporting key strategic and scientific consulting projects within our nimble, high-impact team.

Sofía represents the future of data-driven, personalized healthcare consulting.
See the original announcement below to learn more about Sofía’s background and Svetlana’s growing team.

The upcoming ESMO – European Society for Medical Oncology meeting in Madrid will be a fantastic opportunity for colleagues across the ecosystems of drug development, medical affairs, market access and analytics, sci comm, and HEOR to meet and interact with the Precision Oncology Consulting group.

The key competencies and areas of service focus for clients of the Precision Oncology Consulting team are listed below:

  • Cancer genomics and precision oncology
  • Scientific/medical/commercial positioning and competitive strategy
  • Go-to-market (GTM) strategy and evidence generation
  • Scientific writing and collaborations
  • Key Opinion/Thought Leader (KOL/KTL)/external expert (EE) development and management
  • Scientific Advisory Boards (ABs) and Multidisciplinary Forums
  • Generation of White Papers (WPs) and other special reports (bespoke or federated).”

You can also read:

Svetlana Nikic: Precision Oncology Consulting Strengthens Team With New Scientific Expertise

Nicholas Sarlis: Advancing Precision Oncology Through Emerging Scientific Talent